FindTrial
Sign In

To study the dermoscopic finding of Vitiligo to assess the disease activity.

To study the dermoscopic finding of Vitiligo to assess the disease activity â?? A Cross Sectional Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/028930
Enrollment
200
Registered
2020-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80- Vitiligo

Interventions

None listed

Sponsors

Manal Dave
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All clinically diagnosed cases of vitiligo including patients on treatment.

Exclusion criteria

Exclusion criteria: Patient with Vitiligo Universalis. Patient with depigmentation by other disorder, chemical or burns diagnosed clinically or any other suspected cause of leucoderma by patientâ??s history.

Design outcomes

Primary

MeasureTime frame
ï?? To assess and compare the dermoscopic findings according to the given parameters in the patients of stable and unstable vitiligo.Timepoint: Study will be conducted from Oct 2020 to Sept 2021—

Secondary

MeasureTime frame
ï?? To study any new finding if found in the patient of vitiligo. ï?? To assess the dermoscopic finding in the lesion of vitiligo after treatment. Timepoint: Study will be conducted from Oct 2020 to Sept 2021—

Countries

India

Contacts

Public ContactManal Dave

Govt. Medical College, Bhavnagar

hitamehta88@gmail.com9429503188

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026